Comparison of Two Different Optical Biometric Systems

NCT ID: NCT05411341

Last Updated: 2024-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary objective of this study is to evaluate and compare the measurements of two different optical biometrics systems in patients who will undergo cataract surgery or presbyopia surgery using intraocular lenses (IOL-PC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective study including patients visiting the outpatient Ophthalmology clinic of the University General Hospital of Alexandroupolis, who suffer from diagnosed cataract or presbyopia and are going to undergo implantation of intraocular lenses surgery. The patients will be fully informed about the procedure and the purpose of the study and a written informed consent will be provided by all participants. They will then undergo an ocular biometry examination using two optical biometric systems, Argos (Alcon Laboratories, Inc.) and IOLMaster 500 (Carl Zeiss Meditec AG). IOL Master 500 (Carl Zeiss Meditec AG) is a non-invasive optical biometer that uses partial coherence interferometry (PCI) with a wavelength of 780 nm to measure the AL of the eye. Argos (Alcon Laboratories, Inc.) is a novel non-invasive optical biometer that uses swept source optical coherence tomography (SS-OCT) with a wavelength of 1050 nm. The measurements of the two systems that will be compared are the axial length, the keratometry values, the anterior chamber depth (ACD), the horizontal corneal diameter (white to white \[WTW\]) and the lens power in diopters (D).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract Presbyopia Ocular Biometry Intraocular Lens

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group

100 patients with diagnosed cataract or presbyopia who will undergo implantation of intraocular lenses surgery

Argos (Alcon Laboratories, Inc.)

Intervention Type DEVICE

An ocular biometry examination will be performed on the affected eyes using the Argos device.

IOLMaster 500 (Carl Zeiss Meditec AG)

Intervention Type DEVICE

An ocular biometry examination will be performed on the affected eyes using the IOL Master 500 device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Argos (Alcon Laboratories, Inc.)

An ocular biometry examination will be performed on the affected eyes using the Argos device.

Intervention Type DEVICE

IOLMaster 500 (Carl Zeiss Meditec AG)

An ocular biometry examination will be performed on the affected eyes using the IOL Master 500 device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with cataract and/or presbyopia who will undergo intraocular lens implantation.

Exclusion Criteria

* Dense cataract that does not allow measurements to be taken with an optical biometrics system.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Democritus University of Thrace

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Georgios Labiris

Professor (Associate) of Democritus University of Thrace

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georgios Labiris, MD, PhD

Role: STUDY_CHAIR

Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Ophthalmology, University Hospital of Alexandroupolis

Alexandroupoli, Evros, Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Georgios Labiris, MD, PhD

Role: CONTACT

00302551030405

Eirini - Kanella Panagiotopoulou, MD

Role: CONTACT

00306978730858

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Georgios Labiris, MD, PhD

Role: primary

0030 2551030405

Eleftheria Chalkia

Role: backup

00302551030405

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ES9/Th3/05-05-2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of a Trifocal Lens
NCT04545671 COMPLETED